Australian Clinical Labs (ACL) Director Trades
Insider activity from ASX Appendix 3Y filings.
- Trades shown
- 12
- Bought (value)
- $340,908
- Sold (value)
- $0
- Net sentiment
- +$340,908
| Date | Director | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-09-14 | S Butler | Buy | — | — | — | View |
| 2026-09-10 | Sarah Butler | Buy | 18,000 | $2.77 | $49,860 | View |
| 2026-02-20 | S Butler | Buy | — | — | — | View |
| 2026-02-19 | Sarah Butler | Buy | 22,617 | $2.2104 | $49,994 | View |
| 2025-10-28 | Stephen Roche | Buy | 70,000 | $2.77 | $193,900 | View |
| 2025-10-28 | S Roche | Buy | — | — | — | View |
| 2024-08-29 | Unknown Director | Buy | — | — | — | View |
| 2024-08-26 | Melinda McGrath | Sell | 247,252 | — | — | View |
| 2024-03-05 | Unknown Director | Buy | — | — | — | View |
| 2024-02-28 | Christine Bartlett | Buy | 20,000 | $2.3577 | $47,154 | View |
| 2024-01-04 | Unknown Director | Buy | — | — | — | View |
| 2023-12-20 | Melinda McGrath | Buy | 395,490 | — | — | View |
Source: ASX Appendix 3Y filings (Corporations Act s205G). Director trades must be lodged with the ASX within 14 days of the change in interest. See the official methodology.